Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Jim Cramer’s guide to investing: How to use the ‘new high’ list for stocks
CNBC’s Jim Cramer revealed one of the methods he uses to find winning stocks: The “new high” list. This list shows stocks that are hitting new 52-week highs, and Cramer said it can be a good place to start researching worthwhile investments. “Watch for stocks that have pulled back from the new high list, especially…
You’ll see very strong earnings from General Motors on Tuesday, says Benchmark’s Ward
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Michael Ward, The Benchmark Company auto analyst, and Garrett Nelson, CFRA senior auto analyst, join ‘Power Lunch’ to discuss the bull case for General Motors and Ford, Nelson’s thoughts on Ford in the mid- to long-term and more. 04:32 Mon, Oct 24…
GM’s McNeill on EV market: Headlines are disconnected from the data
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jon McNeill, GM board member and former Tesla president, joins ‘Squawk on the Street’ to discuss why growth is not slowing in the electric vehicle market, if McNeill shares the popular worries for the EV market, and more.
The momentum in the Nasdaq can continue, it’s not overbought, says Ritholtz’s Josh Brown
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Josh Brown, Ritholtz Wealth Management CEO, joins ‘Closing Bell’ to discuss the Nasdaq’s momentum, big bank earnings expectations, and his market outlook. 04:19 Wed, Jan 10 20243:17 PM EST
Google’s antitrust probe heats up
European Commission may be preparing for formal case against Google, according to The Wall Street Journal.
It’s vital to strike the right balance in your portfolio, all-star investor Rich Bernstein suggests
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Futures Now Institutional Investor Hall of Famer Richard Bernstein plots a strategy to weather market uncertainty and risks. 04:34 Mon, Jul 27 20205:56 PM EDT
